• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Swedish Orphan Biovitrum AB

+ Add to Watchlist

SWTUY:US

10.0100 USD 0.2100 2.14%

As of 15:05:03 ET on 12/22/2014.

Snapshot for Swedish Orphan Biovitrum AB (SWTUY)

Open: 10.0000 Day's Range: 10.0000 - 10.0200 Volume: 3,599
Previous Close: 9.8000 52wk Range: 9.2300 - 13.8300 1-Yr Rtn: -2.82%

Stock Chart for SWTUY

No chart data available.
  • SWTUY:US 10.0100
  • 1D
  • 1M
  • 1Y
9.8000
Interactive SWTUY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SWTUY

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 2,706.60
Shares Outstanding (M) 270.39
30 Day Average Volume 659
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 0.3351
Dividend Ex-Date 05/26/2011
5 Year Dividend Growth -
Next Earnings Announcement 02/19/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SWTUY

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for SWTUY

Swedish Orphan Biovitrum AB is a biomedical company. The Company develops and makes available orphan drugs and niche specialty pharmaceuticals for patients with rare diseases and with high unmet medical needs.

Geoffrey McDonoughChief Executive OfficerMats-Olof WallinSenior VP/CFO
Alan RaffenspergerSenior VP/COOBirgitte VolckSenior VP/Chief Medical Ofcr
More Company Profile & Key Executives for SWTUY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil